Cytotoxic activity of aziridinyl putrescine enhanced by polyamine depletion with alpha-difluoromethylornithine.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line; D000518:Eflornithine; D006801:Humans; D008297:Male; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011073:Polyamines / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology; D011700:Putrescine / Q000031:analogs & derivatives* / Q000494:pharmacology
D000970:Antineoplastic Agents; D011073:Polyamines; C045399:aziridinyl putrescine; D009952:Ornithine; D011700:Putrescine; D000518:Eflornithine